מיטוקסנטרון אבווה 2 מגמל

Država: Izrael

Jezik: hebrejski

Izvor: Ministry of Health

Aktivni sastojci:

MITOXANTRONE AS HYDROCHLORIDE

Dostupno od:

NOVARTIS ISRAEL LTD

ATC koda:

L01DB07

Farmaceutski oblik:

תרכיז להכנת תמיסה לאינפוזיה

Sastav:

MITOXANTRONE AS HYDROCHLORIDE 2 MG/ML

Administracija rute:

תוך-ורידי

Tip recepta:

מרשם נדרש

Proizveden od:

EBEWE PHARMA GES.M.B.H NFG. KG, AUSTRIA

Terapijska grupa:

MITOXANTRONE

Područje terapije:

MITOXANTRONE

Terapijske indikacije:

Treatment of advanced breast cancer, non-Hodgkin's lymphomas, acute non lymphocytic leukemia palliation of non resectable primary hepatocellular carcinoma. Mitoxantrone in combination with corticosterolds is indicated for inital chemotherapy in patients with pain due to advanced hormone-refractory prostate cancer. For reduction of neurologic disability and/or frequency of clinical relapses in patients with secondary (chronic) progressive, progressive relapsing, or worsening relapsing-remmitting multiple sclerosis (patients whose neurologic status is significantly abnormal between relapses), for patients 18-55 years old.

Datum autorizacije:

2023-12-31